Skip to main content
Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 14, Number 10, 2013

Articles

Favourites:
ADD

Activation of B Cells by a Dendritic Cell-Targeted Oral Vaccine
pp. 867-877(11)
Authors: Sahay, Bikash; L. Owen, Jennifer; Yang, Tao; Zadeh, Mojgan; L. Lightfoot, Yaima; Ge, Jun-Wei; Mohamadzadeh, Mansour

Favourites:
ADD
Favourites:
ADD

Research Progress in Live Attenuated Brucella Vaccine Development
pp. 887-896(10)
Authors: Wang, Zhen; Wu, Qingmin

Favourites:
ADD

First Steps Towards a Vaccine against Acinetobacter baumannii
pp. 897-902(6)
Authors: Garcia-Quintanilla, Meritxell; R. Pulido, Marina; J. McConnell, Michael

Favourites:
ADD

Shigella Vaccine Development: Prospective Animal Models and Current Status
pp. 903-912(10)
Authors: Kim, Yeon-Jeong; Yeo, Sang-Gu; Park, Jae-Hak; Ko, Hyun-Jeong

Favourites:
ADD

Vaccines against Clostridium perfringens Alpha-toxin
pp. 913-917(5)
Author: Nagahama, Masahiro

Favourites:
ADD

A Mini Review of Biodegradable Calcium Phosphate Nanoparticles for Gene Delivery
pp. 918-925(8)
Authors: Xie, Ying; Chen, Yun; Sun, Minjie; Ping, Qineng

Favourites:
ADD

Mesoporous Materials and Nanocrystals for Enhancing the Dissolution Behavior of Poorly Water-soluble Drugs
pp. 926-938(13)
Authors: A. Santos, Helder; Peltonen, Leena; Limnell, Tarja; Hirvonen, Jouni

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content